Journal of Cancer Therapy

Volume 4, Issue 6 (July 2013)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

Effects of a New Human Recombinant MnSOD in the Treatment of Photoaging and Actinic Keratosis

HTML  XML Download Download as PDF (Size: 319KB)  PP. 56-59  
DOI: 10.4236/jct.2013.46A1009    4,654 Downloads   6,252 Views  

ABSTRACT

Physiological processes, as aerobic metabolism and inflammatory response, generate reactive oxygen species (ROS) that may induce cellular injury when their amount is increased and antioxidant defense mechanisms are overwhelmed. Also, ROS are generated following UV skin irradiation able to deplete the natural antioxidant defenses in the skin. The increase in exposure to UV may lead to photoaging and precancerous skin lesions (actinic keratosis). New antioxidant strategies in the prevention and therapy of skin lesions are urgently needed. In this study, we evaluated the antioxidant efficacy of a recombinant form of human manganese superoxide dismutase able to inhibit reactive oxygen species production in some patients affected by severe photoaging and actinic keratosis.

Share and Cite:

M. Ruggiero, M. Pollio, A. Schiattarella, A. Borrelli, A. Mancini, A. Pica and P. Forgione, "Effects of a New Human Recombinant MnSOD in the Treatment of Photoaging and Actinic Keratosis," Journal of Cancer Therapy, Vol. 4 No. 6A, 2013, pp. 56-59. doi: 10.4236/jct.2013.46A1009.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.